› Forums › General Melanoma Community › Targeted drug attack problems – example from c-kit work
- This topic is empty.
- Post
-
- August 30, 2011 at 7:08 pm
http://mct.aacrjournals.org/content/6/3/1159.full
Long article that discusses c-kit mutations and resistance to treatments.
I would expect similar modes of findings in all of the targeted attacks on different mutations other than just c-kit. This shows what the medical research is up against in attempting to narrow the attack on each mutation in each type of cancer (even within the different types of c-kit melanoma!).
The introduction, results and Discussion sections are especially interesting.
Wish I had a better background to understand the details even better.The article sections are:
Abstract
Introduction
Materials and Methods
c-KIT Expression in FDC-P1 Cells
c-KIT Kinase Inhibitory Drugs
Immunofluorescence Assay
Cell Proliferation Assay
Immunoprecipitation and Western Blot Analysis
Structural Analysis
Results
Expression Levels of c-KIT in FDC-P1 Cells
Preliminary Studies with V654A Mutant c-KIT
Effect of the V654A Substitution in Combination with V560G, an Activating Mutation Characteristic of GIST, on Drug Sensitivity
Effect of Kinase Inhibitors on c-KIT Phosphorylation
Discussion
- You must be logged in to reply to this topic.